Levine Mitchell S 4
4 · OncoCyte Corp · Filed Mar 18, 2019
Insider Transaction Report
Form 4
Levine Mitchell S
Chief Financial Officer
Transactions
- Award
Option to Purchase Common Stock
2019-03-14+245,000→ 245,000 totalExercise: $3.52Exp: 2019-03-13→ Common Stock (245,000 underlying) - Award
Restricted Stock Units
2019-03-14+20,000→ 20,000 total→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]One quarter of the options shall vest upon the completion of one year of continuous service from the date of grant on March 14, 2019 and the balance shall vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, based on continuous service on the applicable vesting date.
- [F2]Grant of restricted stock units under the OncoCye 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Common Stock.
- [F3]The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant.